APP and Alzheimer disease: The extent of 5-HT4 receptor-mediated sAPPα release in CSF could also constitute a biomarker to follow the capacity to induce non-amyloidogenic APP cleavage in AD brains in which the 5-HT4 receptor density is known to be reduced (Reynolds et al., 1995).